The Centers for Medicare & Medicaid Services (CMS) has substantially enhanced its authorities related to provider and supplier enrollment through the issuance of its CY 2027 Home Health Prospective Payment System (HH PPS) final rule, largely effective January 1, 2027. These changes, intended to strengthen CMS’s program integrity protections in a continued shift from what historically had been a “pay and chase” system, affect all Medicare provider and supplier types, notwithstanding that CMS used the Final Home Health Rule as its rulemaking vehicle. In this blog series, we will address the key authority changes most relevant to providers and suppliers participating in Medicare. The first addresses CMS’s new and expanded revocation authorities under 42 CFR § 424.535.
Key Takeaways
- The final rule provides new and broadened authority for revocation, including conduct by owners and managers.
- These authorities apply across all Medicare provider and supplier types, not just to home health agencies.
- CMS can now apply retroactive revocation dates to all revocation authorities, permitting CMS to recoup prior Medicare payments when it finds a provider or supplier was noncompliant.
Background
Effective January 1, 2027, the CY 2027 HH PPS final rule includes wide-reaching updates to the provider enrollment regulations for CMS’s revocation authority at 42 CFR § 424.535.
While originating in the annual payment update for home health agencies, most of these amendments and new authorities apply to all Medicare-enrolled provider and supplier types.
This analysis focuses on the rule’s six substantive amendments to the revocation authority and realigns the effective-date provisions for revocation actions. Changes to the new enrollment authorities will be addressed separately in our next published analysis.
Key Changes in Revocation Authority
False or Misleading Information (§ 424.535(a)(4))
This revocation authority was previously limited to information provided by a provider or supplier on its Medicare enrollment application.
The final rule expands the authority to now include the submission of false or misleading information “on or associated with any CMS or Medicare provider enrollment-related form,” including a nonexhaustive list of documents such as contractor forms, supporting documentation, the CMS-588 EFT agreement, opt-out affidavits, authorized/delegated-official letters, and any other required or requested documentation.
Abuse of Billing Privileges (§ 424.535(a)(8)(ii))
While the substantive standard—having a “pattern or practice of submitting claims that fail to meet Medicare requirements”—remains, CMS has eliminated the prior four-factor framework for determining when such a pattern exists. Now, declining to adopt any numerical definition of “pattern or practice,” CMS will make an open-ended “facts and circumstances” determination.
This represents a continued erosion of the regulatory factors CMS is required to evaluate when determining whether a “pattern or practice” of abusive billing supports revocation. In 2021, CMS eliminated factors including “the length of time over which the pattern existed” and how long a provider had been enrolled in the program, permitting it to use this authority in situations of noncompliance involving even short periods of claims review.
The elimination of the four-factor framework that remained after the 2021 rule changes gives way to a fully discretionary framework for enforcement.
Misdemeanor Convictions for Sexual Assault or Financial Misconduct (§ 424.535(a)(16))
A new revocation authority covers providers, suppliers, or their owners, managing employees, managing organizations, officers, or directors convicted of a federal or state misdemeanor related to sexual assault or financial misconduct within the last 10 years if CMS deems the conviction detrimental to the best interests of the Medicare program and its beneficiaries.
CMS will apply a facts-and-circumstances analysis, similar to that used for felony convictions, and did not define “sexual assault” or “financial misconduct” in the regulation.
Affiliations Posing Undue Risk (§ 424.535(a)(19))
The “affiliations” authority previously allowed CMS to revoke a provider or supplier’s billing privileges only if the provider or supplier itself had an affiliation posing an undue risk of fraud, waste, or abuse.
The amendment expands and clarifies this authority, allowing CMS to reach such affiliations of any owning or managing employees or organizations, substantially broadening CMS’s authority under this open-ended revocation basis.
High Risk Based on Excess Providers in an Area (§ 424.535(a)(24))
This new revocation authority allows CMS to revoke enrollment if it determines that a provider or supplier’s presence in an area with an “excessive number of providers and suppliers” constitutes a high risk of fraud, waste, or abuse.
While CMS emphasized that this provision does not set a numerical cap or require a demonstration of need and is intended for “isolated and very individualized situations” of provider saturation, the agency expressly declined to establish numerical thresholds, mandatory risk factors, categorical exceptions, or a requirement to demonstrate individual misconduct. The breadth of CMS’s discretion for this revocation authority is especially worthy of attention.
Change-in-Majority-Ownership Noncompliance (§ 424.535(a)(25))
CMS can now revoke billing privilege due to noncompliance with the “36-month rule” governing changes in majority ownership of home health agencies, hospices, and DMEPOS suppliers.
The “36-month rule” is a Medicare enrollment restriction that generally prohibits a home health agency or hospice from transferring its Medicare provider agreement and billing privileges to a new owner when a change in majority ownership occurs within 36 months of the agency’s initial Medicare enrollment or its most recent change in majority ownership (42 CFR § 424.550(b)).
CMS clarified that a provider’s misinterpretation of the applicable regulations will not, by itself, excuse noncompliance. Under the existing 36-month rule, CMS had denial authority to certain changes in majority ownership and could prevent the Medicare provider agreement and billing privileges from transferring to the new owner.
The final rule establishes an express basis to revoke enrollment for noncompliance with these requirements, including when CMS discovers a noncompliant ownership transaction after it has occurred.
Structural Change: Retroactive Effective Dates for All Revocations
Prior to the final rule, most revocations took effect prospectively—30 days after notice—except for certain narrow circumstances. Under the final rule, every enumerated revocation authority under § 424.535 will carry a specifically delineated retroactive effective date, generally reaching back to the date the triggering conduct or noncompliance began.
This shift enables CMS to recoup payments made during periods of noncompliance and is intended to incentivize continuous adherence to Medicare requirements.
Implications for Revocation Authority
The new and expanded revocation authorities and retroactive application build upon CMS’s anti-fraud initiatives of 2026 and cement the agency’s “detect and deploy” strategy to combat alleged fraud and abuse in the Medicare program.
Given the new retroactive reach of CMS’s revocation authority, the final rule allows CMS to not only prevent Medicare dollars from going out the door but also recoup supposed improper payments that are paid while a revocation determination is pending. Put simply, the new and expanded authorities coupled with retroactivity present a significant compliance and business risk for all Medicare providers and suppliers.
Accurate information and understanding of the backgrounds and affiliations of stakeholders’ owners, managing employees, and organizations are crucial given the final rule. Moreover, providers or suppliers operating in saturated geographic areas, home health agencies and hospices considering changes in majority ownership, and DMEPOS suppliers are especially at risk for potential revocation.
It is imperative that any major organizational action, including acquisitions, sales, mergers, and substantial personnel changes, be carefully vetted with legal counsel prior to enactment as the ramifications for noncompliance in this new landscape are enormous. Even routine tasks, such as 855 updates, should receive additional internal review prior to submission.
All providers and suppliers should implement, update, and increase compliance monitoring, internal audit, and training programs to address the broader array of revocation triggers.
How Can We Help?
If your organization is considering any major change (such as buying or selling a provider number) or has been affected by an enrollment revocation, contact one of our healthcare lawyers. Stay tuned to Health Law Scan for additional updates in this series on the CY 2027 HH PPS final rule for more key takeaways.